High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis.

Yildiz, Yasar; Kabadayi, Gokhan; Yigit, Seyran; Kucukzeybek, Yuksel; Alacacioglu, Ahmet; Varol, Umut; Taskaynatan, Halil; Salman, Tarik; Oflazoglu, Utku; Akyol, Murat; Tarhan, Mustafa Oktay

Yildiz, Yasar; Kabadayi, Gokhan; Yigit, Seyran; Kucukzeybek, Yuksel; Alacacioglu, Ahmet; Varol, Umut; Taskaynatan, Halil; Salman, Tarik; Oflazoglu, Utku; Akyol, Murat; Tarhan, Mustafa Oktay.

Affiliation

Yildiz Y; Clinic of Medical Oncology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey.

J BUON ; 24(4): 1549-1554, 2019.

Article de En | MEDLINE | ID: mdl-31646807

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cystadénocarcinome séreux / Tumeurs épithéliales épidermoïdes et glandulaires / Protéines liées au GPI / Carcinome épithélial de l'ovaire Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Middle aged Langue: En Journal: J BUON Sujet du journal: NEOPLASIAS Année: 2019 Type de document: Article Pays d'affiliation: Turquie

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links